Related Experiment Video

Updated: Aug 7, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Hypertension and lipids: lipid factors in the hypertension syndrome

Gary E Sander1, Thomas D Giles

  • 1Cardiovascular Research Laboratory, Louisiana State University Health Sciences Center, 1542 Tulane Avenue, New Orleans, LA 70112, USA. gsande@lsuhsc.edu

Current Hypertension Reports
|November 7, 2002
PubMed

Insights

Managing cardiovascular risk factors like hypertension and high cholesterol is crucial. Treating these conditions, for example with statins, can lower blood pressure and reduce overall cardiovascular risk.

Area of Science:

  • Cardiovascular medicine
  • Endocrinology
  • Pharmacology

Background:

  • Cardiovascular risk factors include hypertension, lipid abnormalities, and hyperglycemia, collectively termed "cardiovascular dysmetabolic syndrome."
  • These factors contribute to vascular endothelial damage via increased reactive molecular species, elevating cardiovascular morbidity and mortality.
  • Coexistence of risk factors like hypertension and hypercholesterolemia is common, with low-density lipoprotein cholesterol upregulating the AT(1) receptor and increasing blood pressure.

Purpose of the Study:

  • To explore the interrelationship between cardiovascular risk factors and their impact on vascular health.
  • To investigate how treatments for hypercholesterolemia and hypertension influence associated risk factors and endothelial function.
  • To emphasize the importance of integrated management of multiple cardiovascular risks.

Main Methods:

  • Literature review and analysis of existing research on cardiovascular risk factors and their management.
  • Examination of molecular mechanisms, including the role of low-density lipoprotein cholesterol in AT(1) receptor upregulation.
  • Evaluation of therapeutic interventions such as statins and angiotensin-converting enzyme inhibitors.

Main Results:

  • Statins decrease AT(1) receptor expression and activation, reducing both cholesterol and blood pressure.
  • Angiotensin-converting enzyme inhibitors may also lead to a reduction in cholesterol levels.
  • Effective management of multiple risk factors is key to preserving endothelial function and reducing cardiovascular risk.

Conclusions:

  • Integrated treatment strategies addressing multiple cardiovascular risk factors are essential for effective cardiovascular risk reduction.
  • Minimizing oxidative stress during treatment is critical for maintaining normal endothelial cell function.
  • Pharmacological interventions targeting specific risk factors can have beneficial effects on others, highlighting a systemic approach to cardiovascular health.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction03:42

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

Published on: March 29, 2024

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...